Literature DB >> 7963713

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes are not necessary for heterotypic immunity to influenza.

B S Bender1, W E Bell, S Taylor, P A Small.   

Abstract

Mice transgenic for beta 2-microglobulin deletion (beta 2M-/-) were immunized intranasally with either a recombinant vaccinia virus that expressed both nucleoprotein and interleukin-2 or by infection with H3N2 influenza virus; 3-4 weeks later they were challenged with H1N1 influenza virus. The immunized beta 2M-/- mice had increased survival and enhanced clearance of virus relative to nonimmune controls. This protection correlated with the development of class II major histocompatibility complex-restricted pulmonary cytotoxic T lymphocyte activity and nasal IgA anti-nucleoprotein antibody. Heterotypic immunity can therefore be generated by a mechanism that does not involve class I major histocompatibility complex-restricted T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7963713     DOI: 10.1093/infdis/170.5.1195

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Enhanced mucosal and systemic immune responses to intestinal reovirus infection in beta2-microglobulin-deficient mice.

Authors:  A S Major; C F Cuff
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA.

Authors:  J B Ulmer; T M Fu; R R Deck; A Friedman; L Guan; C DeWitt; X Liu; S Wang; M A Liu; J J Donnelly; M J Caulfield
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 3.  Hallmarks of CD4 T cell immunity against influenza.

Authors:  K K McKinstry; T M Strutt; S L Swain
Journal:  J Intern Med       Date:  2011-03-25       Impact factor: 8.989

4.  Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza.

Authors:  B S Bender; C A Rowe; S F Taylor; L S Wyatt; B Moss; P A Small
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Roles of CD4+ T-cell-independent and -dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T-cell activities that enhance the therapeutic activity of antiviral antibodies.

Authors:  Krystyna Mozdzanowska; Michelle Furchner; Darya Zharikova; Jingqi Feng; Walter Gerhard
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

Authors:  Damian M Carragher; Denise A Kaminski; Amy Moquin; Louise Hartson; Troy D Randall
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

7.  Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains.

Authors:  Jin Hyang Kim; Justine Liepkalns; Adrian J Reber; Xiuhua Lu; Nedzad Music; Joshy Jacob; Suryaprakash Sambhara
Journal:  Vaccine       Date:  2015-12-17       Impact factor: 3.641

8.  Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice.

Authors:  M B Graham; T J Braciale
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

9.  Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytes.

Authors:  Innocent N Mbawuike; Yongxin Zhang; Robert B Couch
Journal:  Respir Res       Date:  2007-06-27

10.  An early CD4+ T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions.

Authors:  Mark Y Sangster; Janice M Riberdy; Maricela Gonzalez; David J Topham; Nicole Baumgarth; Peter C Doherty
Journal:  J Exp Med       Date:  2003-09-29       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.